NASDAQ-GS · traded in Congress
Ultragenyx Pharmaceutical RARE
$14.5778 -0.1922 (-1.30%) Sep 25, 2026 4:31 AM ET
Market value$1.4B
P/E ratio-
Analyst target$24.00
52-week range-
Avg volume3,802,250
Dividend yieldN/A
Chart
Congress trades in RARE
Members of Congress disclosed 2 transactions in RARE in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
| 02/18/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 3/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- Bessent says the U.S. is open to extending the China trade truce that ends Nov. 10, or a bigger deal Economy · September 23, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.